| abstract |
WHICH INCLUDES: A) A COMPLEX OF BIII 890 OR ONE OF ITS PHARMACOLOGICALLY ACCEPTABLE SALTS; AND, B) CYCLODEXTRIN SELECTED FROM Ò-CD, HP-Ò-CD, HP-ß-CD, AND SBE-ß-CD. WHERE THE ACTIVE SUBSTANCE IS BIII 890 HYDROCHLORIDE, WHICH HAS A CONCENTRATION OF 0.3 mg / ml TO 15 mg / ml AND THE ACTIVE SUBSTANCE-CYCLODEXTRIN MOLAR RATIO IS BETWEEN 1: 1 AND 1: 5. SAID COMPOSITION IS APPLIED VIA PARENTERAL OR INTRAVENOUS VIA FOR THE TREATMENT OF CEREBROVASCULAR ACCIDENT. ALSO, SUCH COMPOSITION MAY ALSO CONTAIN A HYDROXYCIDE SELECTED FROM MALIC ACID, LACTIC ACID, TARTARIC ACID AND CITRIC ACID |